Amgen Inc. buy Royal Bank of Canada
Start price
04.02.26
/
50%
€282.50
Target price
04.02.27
€304.45
Performance (%)
27.59%
Price
07.08.26
€355.40
Summary
This prediction is currently active. The prediction currently has a performance of 27.59%. Dividends of €5.04 are taken into consideration when calculating the performance. This prediction currently runs until 04.02.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Amgen Inc. | 6.375% | 6.375% |
| iShares Core DAX® | 2.573% | 3.502% |
| iShares Nasdaq 100 | 4.858% | 0.654% |
| iShares Nikkei 225® | 5.590% | -0.246% |
| iShares S&P 500 | 3.250% | 2.083% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen (NASDAQ:AMGN) had its price target raised by analysts at Royal Bank Of Canada from $335.00 to $360.00. They now have an "outperform" rating on the stock.
Ratings data for AMGN provided by MarketBeat